Hematopoietic cytokines as tumor markers

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 12, 2004, Pages 1347-1354

  Mroczko, Barbara ^a   Szmitkowski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Hematopoietic cytokines; Tumor markers

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CELL RECEPTOR; COLONY STIMULATING FACTOR 1; CYTOKINE; GLYCOPROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MESSENGER RNA; STEM CELL FACTOR; TUMOR MARKER;

BONE MARROW CELL; CANCER CELL CULTURE; CANCER PATIENT; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CYTOKINE RELEASE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; TREATMENT OUTCOME; TUMOR CELL; TUMOR GROWTH;

CYTOKINES; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; MACROPHAGE COLONY-STIMULATING FACTOR; NEOPLASMS; RECEPTORS, CYTOKINE; RNA, MESSENGER; STEM CELL FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 11244346112     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.253     Document Type: Review

References (68)

1. Bence Jones H. Papers on chemical pathology - lecture III. Lancet 1847;2:88-92.
2. Whicher JT, Banks RE. Cytokines as tumour markers. Scand J Clin Lab Invest 1995;55:122-44.
3. Dunlop RJ, Campbell CW. Cytokines and advanced cancer. J Pain Symptom Manage 2000;20:214-32.
4. Cohen S, Bigazzi PE, Yoshida T. Similarities of T cell function in cell-mediated immunity and antibody production. Cell Immunol 1974;12:150-9.
5. Berdel WE, Danhauser RS, Oberberg D, Zafferani M. Effects of hematopoietic growth factors on malignant nonhematopoietic cells. Semin Oncol 1992;19:41-5.
6. Avalos BR, Gasson JC, Hedvat C, Quan SG, Baldwin GC, Weisbart RH, et al. Human granulocyte colony-stimulating factor: biological activities and receptor characterization on hematopoietic cells and small cell lung cancer lines. Blood 1990;75:851-7.
7. Miyagawa K, Chiba S, Shibuya K, Piao YK, Matsuki S, Yokota J, et al. Frequent expression of receptors for granulocyte-macrophage colony-stimulating factor on human nonhematopoietic tumor cell lines. J Cell Physiol 1990;143:483-7.
8. Turner AM, Zsebo KM, Martin F. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 1992;80:374-80.
9. Tani K, Ozawa K, Ogura H, Shimane M., Tsuruta T, Yokota J, et al. Expression of granulocyte and granulocyte-macrophage colony stimulating factors by human non-hematopoietic tumor cells. Growth Factors 1990;3:325-31.
10. Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer 1999;79:40-6.
11. Suzuki M, Ohwada M, Sato I. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies. Oncology 1995;52:128-33.
12. McDermott RS, Deneux L, Mosseri V, Vedrenne J, Clough K, Fourquet A, et al. Circulating macrophage colony-stimulating factor as a marker of tumor progression. E Cytokine Network 2002;13:121-7.
13. Smith MA, Court EL, Smith JG. Stem cell factor: laboratory and clinical aspects. Blood Rev 2001;15:191-7.
14. Glaspy J. Clinical applications of stem cell factor. Curr Opin Hemat 1996;3:223-9.
15. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 1991;78:961-6.
16. Natali PG, Nicotra MR, Sures I, Mottolese M, Botti C, Ullrich A. Breast cancer is associated with loss of the c-kit oncogene product. Int J Cancer 1992;52:713-7.
17. Rygaard K, Nakamura T, Spang-Thomsen M. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor in SCLC cell lines and xenografts. Br J Cancer 1993;67:37-46.
18. Cohen PS, Chan JP, Lipunskaya M, Biedler JL, Seeger RC. Expression of stem cell factor and c-kit in human neuroblastoma. Blood 1994;84:3465-72.
19. Inoue M, Kyo S, Fujita M, Enomoto T, Kondoh G. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res 1994;54:3049-53.
20. Savarese DM, Valiński H, Quesenberry P, Savarese T. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate 1998;34:80-91.
21. Strohmeyer T, Reese D, Press M. Expression of c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. 1995;153:511-5.
22. Toyota M, Hinoda Y, Takaoka A, Makiguchi Y, Takahashi T, Iton F, et al. Expression of c-kit and kit ligand in human colon carcinoma cells. Tumor Biol 1993;14:295-302.
23. Lahm H, Amstad P, Yilmaz A, Borbenyi Z, Wyniger J, Fischer JR, et al. Interleukin 4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells. Cell Growth Differ 1995;6:1111-8.
24. Hassan S, Kinoshita Y, Kawanami Ch, Kishi K, Matsushima Y, Ohashi A, et al. Expression of proto-oncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines. Dig Dis Sci 1998;43:8-14.
25. Mroczko B, Szmitkowski M, Niklinski J. Stem cell factor and granulocyte-macrophage-colony stimulating factor as candidates for tumour markers for non-small-cell lung cancer. Clin Chem Lab Med 1999;37:959-62.
26. Mroczko B, Szmitkowski M, Okulczyk B. Hematopoietic growth factors in colorectal cancer patients. Clin Chem Lab Med 2003;41:646-51.
27. Hsu SM, Hsu PL. Autocrine and paracrine functions of cytokines in malignant lymphomas. Biomed Pharmacother 1994;48:433-44.
28. Nachbaur D, Denz H, Zwierzina H, Schmalzl F, Huber H. Stimulation of colony formation of various human carcinoma cell lines by rhGM-CSF and rhIL-3. Cancer Lett 1990;50:197-201.
29. Berdel WE, Danhauser-Riedl S, Stienhauser G. Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 1989;73:80-3.
30. Nemunaitis J. A comparative review of colony-stimulating factors. Drugs 1997;54:709-29.
31. Dame JB, Chegini N, Christensen RD, Juul SE. The effect of interleukin-1β and tumor necrosis factor-α (TNF-α) on granulocyte macrophage-colony stimulating factor (GM-CSF) production by neuronal precursor cells. Eur Cytokine Network 2002;13:128-33.
32. Baldwin GC, Gasson JC, Kaufman SE, Quan SG, Williams RE, Avalos BR, et al. Nonhematopoietic tumor cells express functional GM-CSF receptors. Blood 1989; 73:1033-7.
33. Baba M, Hasegawa H, Nakayabu M. Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels G-CSF, GM-CSF, and IL-6: the presence of autocrine growth control by G-CSF. Am J Hematol 1995;49:207-16.
34. Rokhlin OW, Griebling TL, Karassina NV, Raines MA, Cohen MB. Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface. Anticancer Res 1996;16:557-64.
35. Dedhar S, Gaboury L, Galloway P, Eaves C. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhematopoietic origin. Proc Natl Acad Sci USA 1988;85:9253-7.
36. Mizuno K, Sone S, Orino E. Autonomous expressions of cytokine genes by human lung cancer cells and their paracrine regulation. Jpn J Cancer 1994;85:179-86.
37. Armstrong CA, Tara DC, Hart CE, Kock A, Luger TA, Ansel JC. Heterogeneity of cytokine production by human malignant melanoma cells. Exp Dermatol 1992;1:37-45.
38. Trutmann M, Terracciano L, Noppen C, Kloth J, Kaspar M, Peterli R, et al. GM-CSF gene expression and protein production in human colorectal cell lines and clinical tumor specimens. Int J Cancer 1998;77:378-85.
39. Kohn EC, Hollister GH, Dipersio JD, Wahl S, Liotta LA, Schiffman E. Granulocyte-macrophage colony-stimulating factor induces melanoma-cell migration. Int J Cancer 1993;53:968-72.
40. Singh RK, Gutman M, Radinsky R. Heterogeneity of cytokine and growth factor gene expression in human melanoma cells with different metastatic potentials. J Interferon Cytokine Res 1995;15:81-7.
41. Sabourin CL, Wang QS, Mallery SR, Nicholson R, Gopalakrishnan R, Lang JS, et al. Analysis of cytokine gene expression in squamous cell carcinoma of the head and neck. Int J Oncol 1996;8:49-56.
42. Pisa P, Halapi E, Pisa EK, Gerdin E, Hising C, Bucht A, et al. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 1992;89:7708-12.
43. Hill AD, Redmond HP, Austin OM, Grace PA, Bouchier-Hayes D. Granulocyte macrophage colony-stimulating factor inhibits tumour growth. Br J Cancer 1993;80:1543-6.
44. Young MR, Young ME, Wright MA. Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors. Exp Hematol 1990;18:806-11.
45. Young MR, Lozano Y, Coogan M. Stimulation of the metastasis properties of Lewis-lung-carcinoma cells by autologous granulocyte macrophage colony-stimulating factor. Int J Cancer 1992;50:628-34.
46. Takeda K, Hatakeyama K, Tsuchiya Y. A correlation between GM-CSF gene expression and metastases in murine tumors. Int J Cancer 1991;47:413-20.
47. Mroczko B, Szmitkowski M, Okulczyk B, Piotrowski Z. Granulocyte-macrophage colony-stimulating factor in patients with colorectal cancer. Folia Histochem Cytobiol 2001;39(Suppl 2):110-1.
48. Sawyers CL, Golde DM, Quan S. Production of granulocyte-macrophage colony stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia. Cancer 1992;69:1342-6.
49. Screenan C, Osiovich H. Myeloid colony-stimulating factors. Arch Pediatr Adolesc 1999;153:984-8.
50. Baba M, Kaito M, Hasegawa H, Nakayabu M, Yoshida Y, Uda Y. Establishment and characterization of a new human thyroid anaplastic cancer cell line that produces human colony-stimulating factor. Mie Med J 1991; 41:155-62.
51. Furihata M, Sonobe H, Ohtsuki Y, Enzan H, Tokuoka H, Nakanuma Y. An immunohistochemical study on a case of granulocyte colony-stimulating factor producing gallbladder carcinoma. Pathol Int 1999;49:1010-3.
52. Hirasawa K, Kitamura T, Oka T, Matsushita H. Bladder tumor producing granulocyte colony-stimulating factor and parathyroid hormone related protein. J Urol 2002;167:2130-6.
53. Uematsu T, Tsuchie K, Ukai K, Kimoto E, Funakawa T, Mizuno R. Granulocyte colony-stimulating factor produced by pancreatic carcinoma. Int J Pancreat 1996;19:135-9.
54. Sugimoto M, Kajimura M, Hanai H, Shirai N, Tanioka F, Kaneko E. G-CSF-producing gastric anaplastic large cell lymphoma complicating esophageal cancer. Dig Dis Sci 1999;44:2035-8.
55. Uemura Y, Nakata H, Kobayashi M, Harada R, Asahi Y, Taguchi H. Regulation of granulocyte colony-stimulating factor and parathyroid hormone-related protein production in lung carcinoma cell line OKa-C-1. Jpn J Cancer Res 2000;91:911-7.
56. Logan TF, Gooding W, Kirkwood JM, Shadduck RK. Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer. Exp Hematol 1996;24:49-53.
57. Tachibana M, Miyakawa A, Tazaki H. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 1995;55:34-8.
58. Mroczko B, Szmitkowski M, Okulczyk B. Granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in colorectal cancer patients. Clin Chem Lab Med 2002;40:351-5.
59. Price LK, Choi HU, Rosenberg L, Stanley ER. The predominant form of secreted colony stimulating factor-1 is a proteoglycan. J Biol Chem 1992;267:2190-9.
60. Rallidis L, Thomaidis KP, Zolindaki MG, Velissaridou AH, Papasteriadis EG. Elevated concentrations of macrophage colony stimulating factor predict worse in-hospital prognosis in unstable angina. Heart 2001;86:92-8.
61. Roth P, Stanley ER. The biology of CSF-1 and its receptor. Curr Top Microbiol Immunol 1992;181:141-67.
62. Kacinski BM, Chambers SK, Stanley ER, Carter D, Tseng P, Scata KA, et al. The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumour marker of neoplastic disease activity in endometrial carcinoma patients. Int J Radiat Oncol Biol Physics 1990;19:619-26.
63. Kacinski BM, Stanley ER, Carter D, Chambers JT, Chambers SK, Kohorn EI, et al. Circulating levels of CSF-1 (M-CSF), a lymphohematopoietic cytokine, may be a useful marker of disease status in patients with malignant ovarian neoplasms. Int J Radiat Oncol Biol Physics 1989;17:159-64.
64. Scholl SM, Lidereau R, Rochefordiere A, Cohen-Solal Le-Nir C, Mosseri V, Nogues C, et al. Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. Breast Cancer Res Treat 1996;39:275-83.
65. Hamilton JA, Whitty GA, Stanton H, Meager A. Effects of macrophage-colony stimulating factor on human monocytes: induction of expression of urokinase-type plasminogen activator, but not of secreted prostaglandin E2, interleukin-6, interleukin-1 or tumor necrosis factor-alpha. J Leukoc Biol 1993;53:707-14.
66. Yee LS, Liu L. The constitutive production of colony stimulating factor 1 by invasive human breast cancer cells. Anticancer Res 2000;20:4379-84.
67. Chambers SK, Wang Y, Gertz RE, Kacinski BM. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res 1995;55:1578-85.
68. Mancino AT, Klimberg VS, Yamamoto M, Manolagas SC, Abe E. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells. J Surg Res 2001;100:18-24.